Why Summits

World Drug Safety Summit

5–6 Jun 2025 | Basel, Switzerland

ALWIS

Solution provider

alwisgroup.com/Milton Keynes, United Kingdom
4 profile visits

About

Pioneering drug innovation with Next-Gen tech, we revolutionize safety monitoring and management.

A team of specialists, passionate about innovation, harnessing AI, NLP, and ML to revolutionise drug safety monitoring and management.

Healthcare systems today amass extensive data from diverse sources and languages. Medical AI, NLP, and ML technologies transform this data into structured formats, simplifying drug safety monitoring and enhancing business outcomes. These advancements enable analysis of vast datasets from Electronic Health Records, clinical trials, and social media to identify potential adverse drug events. Furthermore, generative AI and large language models empower pharmacovigilance professionals to navigate complex regulatory landscapes efficiently. Our products ensure PV processes remain compliant with the latest standards, streamlining data-driven decision-making and improving operational efficiency in drug safety monitoring.

  • Integrating AI, NLP, ML, and LLM into Life science offerings

  • Enhanced Drug Safety Monitoring and Management.

  • Efficient Detection and Assessment of Adverse Events

  • Ensuring Patient Safety and Advancing the field of Pharmacovigilance.

Social media

Pharmacovigilance Operations

Individual Case Safety Report (ICSR) managementSignal detection and evaluationRisk Management Plan (RMP) development

Regulatory Affairs & Compliance

PV regulatory intelligence (GVP, FDA, local guidelines)

Data Science, RWE, and Analytics

Use of Real-World Data (RWD) and Real-World Evidence (RWE)

Digital Innovation & AI in PV

Automation of safety reporting and workflows

Representatives

Abdul Rahim

Founder & Director

ALWIS